Physician

Hematology

Dr. Thomas J. Ervin, MD

Doctor Thomas J. Ervin, MD practices Hematology. He went to University of Rochester School of Medicine and Dentistry. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Thomas Ervin is a published doctor and has 50 publications published. The lastest was: 'Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study usin...'

Publications

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine.
A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced N...
Development of methotrexate resistance in a human squamous cell Carcinoma of the head and neck in culture.
A phase I trial of combination therapy with continuous-infusion PALA and continuous-infusion 5-FU.
Phenotypic heterogeneity in cultured human head and neck squamous cell Carcinoma lines with low-level methotrexate resistance.
Phase II study of oral idarubicin in favorable histology non-Hodgkin's Lymphoma.
Radiobiologic research for head and neck Cancer therapy. Therapeutic implications.
Chemical modulation of the hypoxic fraction in the treatment of head and neck Cancer.
Phase II trial of combination therapy with continuous-infusion PALA and bolus-injection 5-FU.
Successful treatment of recurrent primary central nervous system Lymphoma with high-dose methotrexate.
Results of xenogeneic I-RNA therapy in patients with metastatic renal cell Carcinoma.
Hexamethylene bisacetamide in myelodysplastic syndrome and Acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent.
Improved survival for patients with advanced Carcinoma of the head and neck treated with methotrexate-leucovorin prior to definitive radiotherapy or surgery.
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-Cancer patients.
In vivo effect and parallel in vitro lymphocyte-mediated tumor cytolysis after Phase I xenogeneic Immune RNA treatment of patients with widespread melanoma or metastat...
Phase I-II trial of high-dose epirubicin in patients with Lymphoma.
Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment.
Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autogr...
Side effects of chemotherapy. Case 3. Acute interstitial pneumonitis related to gemcitabine.
Primary Lymphomas of the central nervous system: patterns of failure and factors that influence survival.
Phase II trial of ifosfamide and mesna in previously treated patients with non-Hodgkin''s lymphoma: Cancer and Leukemia Group B study 8552.
Phase II trial of ifosfamide and mesna in previously treated patients with non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study 8552.
Small cell Carcinomas of the larynx: results of combined modality treatments.
The role of chemotherapy for advanced Carcinoma of the supraglottic and glottic larynx.
Multidisciplinary treatment of advanced squamous Carcinoma of the head and neck.
Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell Carcinoma of the head and neck: a comparative study usin...
Chemotherapy for advanced Carcinoma of the head and neck. A clinical update.
Oral complications of multimodality therapy for advanced squamous cell Carcinoma of head and neck.
Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast Cancer. TLC D-99 Study Group.
Role of chemotherapy in the multidisciplinary approach to advanced head and neck Cancer: potentials and problems.
Chemotherapy of advanced salivary gland Neoplasms.
Treatment of perineural metastasis from squamous Carcinoma of the skin with aggressive combination chemotherapy and irradiation.
Phase I study of continuous-infusion cisplatin.
Pathology of surgery after induction chemotherapy: an Analysis of resectability and locoregional control.
Adjuvant chemotherapy for resectable squamous cell Carcinomas of the head and neck: report on Intergroup Study 0034.
The influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: secondary Analysis of RTOG 85-03.
Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamou...
The syndrome of inappropriate antidiuretic hormone secretion associated with induction chemotherapy for squamous cell Carcinoma of the head and neck.
Cisplatin, continuous-infusion 5-fluorouracil, and intermediate-dose methotrexate in the treatment of unresectable non-small cell Carcinoma of the lung.
Chemotherapeutic strategies in the multidisciplinary treatment of head and neck Cancer.
Treatment of advanced squamous cell Carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).
Toxicity of aggressive multimodality therapy including cisplatinum, bleomycin and methotrexate with radiation and/or surgery for advanced head and neck Cancer.
An Analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck.
Incidence of hypothyroidism following multimodality treatment for advanced squamous cell Cancer of the head and neck.
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell Carcinoma of the head ...
Advanced squamous Carcinoma of the head and neck. A preliminary report of neoadjuvant chemotherapy with cisplatin, bleomycin, and methotrexate.
Combined modality treatment of head and neck Cancer with cisplatin, bleomycin, methotrexate-leucovorin chemotherapy.
Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.
Cisplatin and fluorouracil alone or with docetaxel in head and neck Cancer.

Schools

University Of Rochester School Of Medicine and Dentistry

Procedures Preformed

Thoracentesis

Conditions Treated

Acute Leukemia
Anal and Rectal Cancer
Anemia
Bladder Cancer
View All

Doctors Specialties

Hematology
Medical Oncology
Oncology

Accepted Insurances

Awards

CMS Meaningful Use Stage 1 Certification

Education

Beth Israel Deaconess Medical Center
University of Rochester
University of Rochester School of Medicine and Dentistry

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Noel A. Maun, MD This Doctor is OpenDoctor Recommended.
	Dr. Robin D. Lifton, MD This Doctor is OpenDoctor Recommended.
	Dr. Mehnaz A. Junagadhwalla, MD This Doctor is OpenDoctor Recommended.
	Dr. Andres O. Soriano, MD This Doctor is OpenDoctor Recommended.
	Dr. James R. Rubinsak, MD This Doctor is OpenDoctor Recommended.
	Dr. Stephen V. Orman, MD This Doctor is OpenDoctor Recommended.
	Dr. Mohan S. Khurana, MD This Doctor is OpenDoctor Recommended.